Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.

Author:

Chi Yihebali1,Sun Yongkun2,Cai Jianqiang3,Yao Yang4,Hong Xiaonan5,Fang Zhiwei6,Sun Ping7,Wang Guowen8,Wu Qiong9,Qu Guofan10,Wang Shusen11,Song Jianmin12,Yu Jianchun13,Lu Yongkui14,Zhu Xia15,Niu Xiaohui16,He Zhiyong17

Affiliation:

1. Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China;

2. Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China;

3. Cancer Institute and Hospital CAMS, Chinese Academy of Medical Sciences, beijing, China;

4. Sixth Affiliated Hospital of Jiaotong University, Shanghai, China;

5. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;

6. Beijing Cancer Hospital, Beijing, China;

7. Liaoning Cancer Hospital & Institute, Shenyang, China;

8. Tianjin Medical University Cancer Institute & Hospital, Tianjin, China;

9. The First Affiliated Hospital of Bengbu Medical College, Bengbu, China;

10. Harbin Medical University Cancer Hospital, Harbin, China;

11. Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China;

12. Gansu Provincial Cancer Hospital, Lanzhou, China;

13. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

14. Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;

15. The First Affiliated Hospital of Fujian Medical University, Fuzhou, China;

16. Department of Orthopedic Oncology Surgery, Beijing Ji Shui Tan Hospital, Peking University, Beijing, China;

17. Fujian Provincial Cancer Hospital, Fuzhou, China;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3